Ladenburg Thalmann Financial Services’s Lineage Cell Therapeutics LCTX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio LCTX Stock Details LCTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Sell	182 -5,073	-97%	-$4.23K	﹤0.01%	5416
2019 Q3	$5K	Hold	5,255	–	–	﹤0.01%	4687
2019 Q2	$6K	Hold	5,255	–	–	﹤0.01%	4643
2019 Q1	$7K	Buy	5,255 +255	+5%	+$317	﹤0.01%	4532
2018 Q4	$5K	Sell	5,000 -715	-13%	-$1.09K	﹤0.01%	4596
2018 Q3	$12K	Hold	5,715	–	–	﹤0.01%	4185
2018 Q2	$13K	Hold	5,715	–	–	﹤0.01%	4096
2018 Q1	$13K	Hold	5,715	–	–	﹤0.01%	4096
2017 Q4	$11K	Hold	5,715	–	–	﹤0.01%	4134
2017 Q3	$14K	Buy	+5,715	New	+$14.2K	﹤0.01%	3891
2017 Q1	–	Sell	-457	Closed	-$1K	–	4913
2016 Q4	$1K	Sell	457 -486	-52%	-$1.49K	﹤0.01%	4669
2016 Q3	$4K	Hold	943	–	–	﹤0.01%	4264
2016 Q2	$2K	Buy	943 +457	+94%	+$1.12K	﹤0.01%	4406
2016 Q1	$1K	Sell	486 -41	-8%	-$91	﹤0.01%	4528
2015 Q4	$2K	Hold	527	–	–	﹤0.01%	4359
2015 Q3	$1K	Hold	527	–	–	﹤0.01%	4426
2015 Q2	$2K	Hold	527	–	–	﹤0.01%	4353
2015 Q1	$2K	Hold	527	–	–	﹤0.01%	4279
2014 Q4	$2K	Hold	527	–	–	﹤0.01%	4055
2014 Q3	$1K	Buy	+527	New	+$1.27K	﹤0.01%	3802
2014 Q2	–	Sell	-496	Closed	-$1K	–	3933
2014 Q1	$1K	Sell	496 -495	-50%	-$1.46K	﹤0.01%	3635
2013 Q4	$3K	Hold	991	–	–	﹤0.01%	3414
2013 Q3	$3K	Hold	991	–	–	﹤0.01%	3348
2013 Q2	$3K	Buy	+991	New	+$3.17K	﹤0.01%	3231

Other funds holding LCTX

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Ladenburg Thalmann Financial Services's LCTX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Lineage Cell Therapeutics (LCTX) stake by 97% in Q4 2019, selling an estimated $4.23K and leaving 182 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5416.

Ladenburg Thalmann Financial Services first reported a position in LCTX in Q2 2013 and has held it in 24 quarters since. The position peaked at $14K in Q3 2017. 108 funds tracked by Wall St. Rank hold LCTX as of Q4 2019.

Ladenburg Thalmann Financial Services held 182 shares of Lineage Cell Therapeutics worth $0 as of Q4 2019.
Ladenburg Thalmann Financial Services sold 5,073 Lineage Cell Therapeutics shares in Q4 2019, an estimated $4.23K.
Lineage Cell Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5416 holding.
Ladenburg Thalmann Financial Services first reported a position in Lineage Cell Therapeutics in Q2 2013 and has held it in 24 quarters since.
Ladenburg Thalmann Financial Services's Lineage Cell Therapeutics position peaked at $14K in Q3 2017.
108 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.